Mifepristone for Treatment of Metabolic Syndrome: Beyond Cushing’s Syndrome

A growing body of research indicates that cortisol, the glucocorticoid product of the activation of the hypothalamic-pituitary-adrenal axis, plays a role in the pathophysiology of metabolic syndrome. In this regard, chronic exposure to cortisol is associated with risk factors related to metabolic sy...

Descripción completa

Detalles Bibliográficos
Autores principales: Díaz-Castro, Francisco, Monsalves-Álvarez, Matías, Rojo, Leonel E., del Campo, Andrea, Troncoso, Rodrigo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7193078/
https://www.ncbi.nlm.nih.gov/pubmed/32390830
http://dx.doi.org/10.3389/fphar.2020.00429

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7193078/
https://www.ncbi.nlm.nih.gov/pubmed/32390830
http://dx.doi.org/10.3389/fphar.2020.00429

Ejemplares similares